European equities traded in the US as American depositary receipts were higher late Tuesday morning, up 0.73% to 1,435.56 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and furniture maker Natuzzi (NTZ), which rose 4.8% and 3.5% respectively. They were followed by oil and gas company TotalEnergies (TTE) and financial services company ING Groep (ING), which were up 2.9% and 2.5% respectively.
The decliners from continental Europe were led by biotech company Evaxion Biotech (EVAX) and biopharmaceutical company DBV Technologies (DBVT), which dropped 5.4% and 3.8% respectively. They were followed by pharmaceutical company Ascendis Pharma (ASND) and biotech company BioNTech (BNTX), which were down 1.6% and 1.2% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company NuCana (NCNA) and software firm Endava (DAVA), which advanced 8.3% and 3% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and oil and gas company Shell (SHEL), which were up 2.7% and 2.1% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical firms Adaptimmune Therapeutics (ADAP) and Biodexa Pharmaceuticals (BDRX), which dropped 9% and 6.9% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and pharmaceutical company Silence Therapeutics (SLN), which lost 5% and 4% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。